FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Transcatheter Septal Occluder
PMA: P000039
·
Supplement: S071
·
Decision Oct 6, 2020
Classifications
1
FEI Numbers
11
Registration Numbers
11
Basic Information
- Device Name
- Transcatheter Septal Occluder
- Trade Name
- AMPLATZER Septal Occluder and AMPLATZER Multi-Fenestrated Septal (Cribriform) Occluder
- PMA Number
- P000039
- Supplement Number
- S071
- Device Class
- FDA Class 3
- Product Code
- MLV
- Generic Name
- Transcatheter septal occluder
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- October 6, 2020
- Date Received
- April 6, 2020
- Supplement Type
- 135 Review Track For 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Approval for a process change in the manufacture of the polyester used in the AMPLATZER device family.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MLV | Transcatheter Septal Occluder | FDA class 3 | Unknown |